Technical Trend Overview and Price Movement
Lupin’s current share price stands at ₹2,235.00, down 1.15% from the previous close of ₹2,261.00. The stock traded within a range of ₹2,230.10 to ₹2,265.00 today, remaining below its 52-week high of ₹2,530.00 but comfortably above the 52-week low of ₹1,881.80. This price action reflects a consolidation phase after a period of upward momentum.
The technical trend has shifted from mildly bullish to sideways, indicating a pause in the stock’s directional movement. This is corroborated by the Moving Average Convergence Divergence (MACD) indicator, which is mildly bearish on both weekly and monthly timeframes. The MACD’s bearish crossover suggests waning upward momentum, signalling caution for traders relying on momentum-based strategies.
Momentum Oscillators and Volatility Indicators
The Relative Strength Index (RSI) on weekly and monthly charts currently shows no clear signal, hovering in a neutral zone that neither indicates overbought nor oversold conditions. This neutrality suggests that the stock is not exhibiting extreme momentum in either direction, reinforcing the sideways trend narrative.
Bollinger Bands present a mixed picture: weekly bands are bearish, indicating increased volatility and potential downward pressure, while monthly bands remain mildly bullish, hinting at longer-term support for the stock. This divergence between short- and long-term volatility measures highlights the complexity of Lupin’s current technical setup.
Additional Technical Indicators: KST, Dow Theory, and OBV
The Know Sure Thing (KST) indicator, a momentum oscillator, aligns with the MACD’s bearish tone on both weekly and monthly charts, signalling a mild bearish momentum. Meanwhile, Dow Theory assessments reveal a mildly bearish weekly outlook but a bullish monthly perspective, suggesting that while short-term trends are under pressure, the longer-term uptrend remains intact.
On the volume front, the On-Balance Volume (OBV) indicator is mildly bearish across weekly and monthly periods, indicating that volume trends are not supporting a strong price advance. This volume weakness could limit the stock’s ability to break decisively higher in the near term.
Our current Stock of the Month is out! This Large Cap from Automobiles - Passenger Cars emerged as the single best opportunity from our elite universe. Get the details now!
- - Current monthly selection
- - Single best opportunity
- - Elite universe pick
Moving Averages and Daily Technical Signals
Despite the bearish undertones on weekly and monthly charts, daily moving averages maintain a mildly bullish stance. This suggests that short-term price action retains some upward bias, possibly reflecting intraday or near-term buying interest. However, this mild bullishness is tempered by the broader sideways trend and bearish momentum indicators, indicating that any rallies may face resistance.
Investors should note that the interplay between daily bullish signals and weekly/monthly bearish momentum often precedes periods of consolidation or volatility, underscoring the importance of monitoring these indicators closely for confirmation of trend direction.
Mojo Score and Grade Revision
Lupin’s Mojo Score currently stands at 64.0, reflecting a Hold rating, a downgrade from the previous Buy grade assigned on 14 Aug 2026. This revision aligns with the technical deterioration observed in momentum and volume indicators. The mid-cap pharmaceutical company’s downgrade signals a more cautious stance from analysts, urging investors to weigh the risks of a potential correction or extended sideways movement against the stock’s longer-term growth prospects.
The downgrade also reflects Lupin’s recent relative underperformance compared to the broader market. Over the past week and month, Lupin’s stock returns have declined by 5.3% and 9.49% respectively, while the Sensex gained 0.62% and 1.24% over the same periods. This divergence highlights the stock’s vulnerability in the short term despite its strong year-to-date and multi-year performance.
Long-Term Performance Context
Over the year-to-date period, Lupin has delivered a positive return of 5.82%, outperforming the Sensex, which is down 8.46%. Over the past year, Lupin’s stock has appreciated by 14.04%, while the Sensex declined by 3.21%. The company’s three- and five-year returns are particularly impressive at 106.62% and 128.86% respectively, significantly outpacing the Sensex’s 19.28% and 40.72% gains. However, over a 10-year horizon, Lupin’s 41.56% return trails the Sensex’s robust 177.10% growth, reflecting sector-specific challenges and market cycles.
Holding Lupin Ltd. from Pharmaceuticals & Biotechnology? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Investor Takeaway and Outlook
The current technical landscape for Lupin Ltd. suggests a period of consolidation and cautious trading ahead. The mildly bearish weekly and monthly momentum indicators, combined with a sideways trend and a Hold rating, imply that investors should temper expectations for near-term gains. However, the stock’s strong multi-year performance and positive longer-term technical signals, such as the monthly Dow Theory bullishness and mildly bullish Bollinger Bands, indicate that Lupin retains fundamental strength within the Pharmaceuticals & Biotechnology sector.
Investors with a medium- to long-term horizon may consider maintaining exposure while closely monitoring key technical levels and volume trends for signs of renewed momentum. Conversely, short-term traders might adopt a more defensive approach, awaiting clearer directional cues before committing fresh capital.
Given the mixed signals, a balanced strategy that incorporates technical analysis alongside fundamental assessment will be essential to navigate Lupin’s evolving market dynamics effectively.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
